Hippocrates MD1-118


Mail Icon Google+ Facebook Twitter

Product Image

 Improve your crystals with the drug-like additives from Morpheus III.

The Hippocrates additive screen contains all the drug-like compounds from the new Morpheus® III in a single additive screen. Exclusively from Molecular Dimensions, it contains a range of unique, small, drug-like compounds to aid protein stabilisation and crystallisation.

Read here about how Morpheus III and Hippocrates can help your screening efforts by expanding the range of chemical space you screen.

Gorrec, F. The Morpheus II protein crystallization screen. Acta Crystallographica section F Structural Biology Communications 71: 831-837 (2015).
Gorrec, F. The current approach to initial crystallization screening of proteins is under-sampled. Journal of Applied Crystallography 46: 795-7 (2013).
Gorrec, F. The MORPHEUS protein crystallization screen. Journal Applied Crystallography 42: 1035-42.

The Morpheus® III screen was developed at the MRC-LMB, Cambridge, UK and exclusively licensed to Molecular Dimensions by LifeARC.




Europe & the
rest of the world

The Innovation Centre
217 Portobello,
S1 4DP, UK

Phone +44 (0) 114 224 2257

Technical: enquiries@moleculardimensions.com
Sales: orders@moleculardimensions.com

Privacy Policy

USA, Canada, Mexico,
Central & South America

6201 Trust Dr.
OH 43528

Phone +1 877 479 4339 / +1 407 886 6901
Fax +1 321 972-8896
Technical: enquiries@moleculardimensions.com
Sales: usorders@moleculardimensions.com

Follow us

FB Like Icon Twitter Icon

LinkedIn Icon

YouTube Icon

Pinterest Icon